TY - JOUR
T1 - The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma
AU - Murthy, Santosh B.
AU - Patnana, Srikrishna V.
AU - Xiao, Lianchun
AU - Rohren, Eric
AU - Hofstetter, Wayne L.
AU - Swisher, Stephen G.
AU - Liao, Zhongxing
AU - Lee, Jeffrey H.
AU - Bhutani, Manoop S.
AU - MacApinlac, Homer A.
AU - Wang, Xuemei
AU - Ajani, Jaffer A.
PY - 2010/9
Y1 - 2010/9
N2 - Background: Empirical trimodality (TM) or bimodality (BM) approaches lead to unpredictable outcomes in patients with localized gastroesophageal carcinoma (LGC). We hypothesized that the standardized uptake value (SUV) of positron emission tomography (PET) after chemoradiation would define the clinical outcome in patients. Methods: We analyzed272 (TM = 155 and BM = 117) LGC patients after chemoradiation PET and studied its association with overall survival (OS) and disease-free survival (DFS). The log-rank test, multivariate Cox proportional hazards model, and Kaplan-Meier survival plots were used to analyze the dichotomized data (using the median as a cutoff). Results: The median survival of TM patients was 49 months (95% CI: 36 to not reached) and that of BM patients was 20 months (95% CI: 15-34; p < 0.0001); however, if the postchemoradiation SUV was <4.6 (4.6 = median SUV), the OS of TM and BM patients was not significantly different (p = 0.22). In the multivariate Cox model, postchemoradiation SUV (p = 0.02), baseline stage (p = 0.03), histology grade (p = 0.01), and having surgery (p = 0.004) were independent prognosticators for OS and DFS. Conclusions: These data document that the low postchemoradiation SUV in both TM and BM patients defines clinical aggression and has a similar clinical outcome. Systematic validation of PET changes, in this setting, can facilitate individualization of therapy of LGC patients.
AB - Background: Empirical trimodality (TM) or bimodality (BM) approaches lead to unpredictable outcomes in patients with localized gastroesophageal carcinoma (LGC). We hypothesized that the standardized uptake value (SUV) of positron emission tomography (PET) after chemoradiation would define the clinical outcome in patients. Methods: We analyzed272 (TM = 155 and BM = 117) LGC patients after chemoradiation PET and studied its association with overall survival (OS) and disease-free survival (DFS). The log-rank test, multivariate Cox proportional hazards model, and Kaplan-Meier survival plots were used to analyze the dichotomized data (using the median as a cutoff). Results: The median survival of TM patients was 49 months (95% CI: 36 to not reached) and that of BM patients was 20 months (95% CI: 15-34; p < 0.0001); however, if the postchemoradiation SUV was <4.6 (4.6 = median SUV), the OS of TM and BM patients was not significantly different (p = 0.22). In the multivariate Cox model, postchemoradiation SUV (p = 0.02), baseline stage (p = 0.03), histology grade (p = 0.01), and having surgery (p = 0.004) were independent prognosticators for OS and DFS. Conclusions: These data document that the low postchemoradiation SUV in both TM and BM patients defines clinical aggression and has a similar clinical outcome. Systematic validation of PET changes, in this setting, can facilitate individualization of therapy of LGC patients.
KW - 18-Fluorodeoxyglucose positron emission tomography
KW - Chemoradiation
KW - Localized gastroesophageal carcinoma
UR - http://www.scopus.com/inward/record.url?scp=77953171024&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953171024&partnerID=8YFLogxK
U2 - 10.1159/000319938
DO - 10.1159/000319938
M3 - Article
C2 - 20699623
AN - SCOPUS:77953171024
VL - 78
SP - 316
EP - 322
JO - Oncology (Williston Park, N.Y.)
JF - Oncology (Williston Park, N.Y.)
SN - 0890-9091
IS - 5-6
ER -